Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities

2020-02-14T14:22:30+00:00

Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. MAHs are obliged to submit the conclusions of risk evaluations for all of their medicinal products containing [...]